These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28247579)

  • 21. Relationship of urinary liver-type fatty acid-binding protein with cardiovascular risk factors in the Japanese population without chronic kidney disease: Sasayama study.
    Kubota Y; Higashiyama A; Marumo M; Konishi M; Yamashita Y; Okamura T; Miyamoto Y; Wakabayashi I
    BMC Nephrol; 2021 May; 22(1):189. PubMed ID: 34020611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary Liver-Type Fatty Acid-Binding Protein Predicts Residual Renal Function Decline in Patients on Peritoneal Dialysis.
    Torigoe K; Muta K; Tsuji K; Yamashita A; Ota Y; Kitamura M; Mukae H; Nishino T
    Med Sci Monit; 2020 Dec; 26():e928236. PubMed ID: 33347426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy.
    Nakamura T; Sugaya T; Node K; Ueda Y; Koide H
    Am J Kidney Dis; 2006 Mar; 47(3):439-44. PubMed ID: 16490622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of the measurements of urinary liver-type fatty acid binding protein levels in patients with acute coronary syndrome.
    Matsumori R; Shimada K; Kiyanagi T; Hiki M; Fukao K; Hirose K; Ohsaka H; Miyazaki T; Kume A; Yamada A; Takagi A; Ohmura H; Miyauchi K; Daida H
    J Cardiol; 2012 Sep; 60(3):168-73. PubMed ID: 22658694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between Urinary Liver-Type Fatty Acid-Binding Protein (L-FABP) and Sarcopenia in Spontaneously Diabetic Torii Fatty Rats.
    Tanabe J; Ogura Y; Kosaki K; Nagai Y; Sugaya T; Ohata K; Watanabe S; Ichikawa D; Inoue K; Hoshino S; Kimura K; Maeda S; Shibagaki Y; Kamijo-Ikemori A
    J Diabetes Res; 2020; 2020():7614035. PubMed ID: 32405506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction.
    Holzscheiter L; Beck C; Rutz S; Manuilova E; Domke I; Guder WG; Hofmann W
    Clin Chem Lab Med; 2014 Apr; 52(4):537-46. PubMed ID: 24243749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary markers in the early stage of nephropathy in patients with childhood-onset type 1 diabetes.
    Suh JS; Kim SH; Cho KS; Jung IA; Cho WK; Jeon YJ; Jung MH; Suh BK
    Pediatr Nephrol; 2016 Apr; 31(4):623-31. PubMed ID: 26525196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low levels of urinary liver-type fatty acid-binding protein may indicate a lack of kidney protection during aortic arch surgery requiring hypothermic circulatory arrest.
    Mori Y; Sato N; Kobayashi Y; Ochiai R
    J Clin Anesth; 2014 Mar; 26(2):118-24. PubMed ID: 24582841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules.
    Kamijo A; Sugaya T; Hikawa A; Okada M; Okumura F; Yamanouchi M; Honda A; Okabe M; Fujino T; Hirata Y; Omata M; Kaneko R; Fujii H; Fukamizu A; Kimura K
    Am J Pathol; 2004 Oct; 165(4):1243-55. PubMed ID: 15466390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fat emulsion given to very low-birthweight infants increases urinary L-FABP.
    Suganuma H; Ikeda N; Ohkawa N; Nagata S; Shoji H; Shimizu T
    Pediatr Int; 2014 Apr; 56(2):207-10. PubMed ID: 24106822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of urinary liver-type fatty acid-binding protein as a predictor of ESRD and CVD in patients with CKD.
    Matsui K; Kamijo-Ikemori A; Imai N; Sugaya T; Yasuda T; Tatsunami S; Toyama T; Shimizu M; Furuichi K; Wada T; Shibagaki Y; Kimura K
    Clin Exp Nephrol; 2016 Apr; 20(2):195-203. PubMed ID: 26189083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary liver-type fatty acid-binding protein level as a predictive biomarker of contrast-induced acute kidney injury.
    Manabe K; Kamihata H; Motohiro M; Senoo T; Yoshida S; Iwasaka T
    Eur J Clin Invest; 2012 May; 42(5):557-63. PubMed ID: 22070248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct roles of urinary liver-type fatty acid-binding protein in non-diabetic patients with anemia.
    Imai N; Yasuda T; Kamijo-Ikemori A; Shibagaki Y; Kimura K
    PLoS One; 2015; 10(5):e0126990. PubMed ID: 26010898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased Urinary Liver-Type Fatty Acid-Binding Protein Level Predicts Major Adverse Cardiovascular Events in Patients With Hypertension.
    Okubo Y; Nakano Y; Tokuyama T; Hironobe N; Okamura S; Ikeuchi Y; Miyauchi S; Kihara Y
    Am J Hypertens; 2020 Jul; 33(7):604-609. PubMed ID: 32155236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary L-FABP as a marker of vesicoureteral reflux in children: could it also have a protective effect on the kidney?
    Benzer M; Tekin Neijmann S; Gültekin ND; Uluturk Tekin A
    Int Urol Nephrol; 2017 Jan; 49(1):1-12. PubMed ID: 27550232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of pioglitazone on urinary liver-type fatty acid-binding protein concentrations in diabetes patients with microalbuminuria.
    Nakamura T; Sugaya T; Kawagoe Y; Ueda Y; Koide H
    Diabetes Metab Res Rev; 2006; 22(5):385-9. PubMed ID: 16506273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary NGAL, KIM-1 and L-FABP concentrations in antenatal hydronephrosis.
    Noyan A; Parmaksiz G; Dursun H; Ezer SS; Anarat R; Cengiz N
    J Pediatr Urol; 2015 Oct; 11(5):249.e1-6. PubMed ID: 26096437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urine liver fatty acid binding protein and chronic kidney disease progression.
    Khatir DS; Bendtsen MD; Birn H; Nørregaard R; Ivarsen P; Jespersen B; Buus NH
    Scand J Clin Lab Invest; 2017 Nov; 77(7):549-554. PubMed ID: 28745927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Azelnidipine reduces urinary protein excretion and urinary liver-type fatty acid binding protein in patients with hypertensive chronic kidney disease.
    Nakamura T; Sugaya T; Kawagoe Y; Suzuki T; Ueda Y; Koide H; Inoue T; Node K
    Am J Med Sci; 2007 Jun; 333(6):321-6. PubMed ID: 17570983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary liver-type fatty acid-binding protein in septic shock: effect of polymyxin B-immobilized fiber hemoperfusion.
    Nakamura T; Sugaya T; Koide H
    Shock; 2009 May; 31(5):454-9. PubMed ID: 18838948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.